In Xenopus laevis, the laryngeal neuromuscular synapse is the final effector for sexually differentiated song production. Females have stronger laryngeal synapses than males, and synapse strength is estrogen dependent. Estrogen-induced increases in synaptic strength require at least 3 weeks of exposure, suggesting that the hormone acts via a classical genomic mechanism involving the estrogen receptor (ER). The locus of the sex difference in synapse strength, determined using quantal analysis, is presynaptic, leading to the prediction that estrogen acts directly on vocal motor neurons. However, laryngeal motor neurons do not accumulate estrogen. Estrogen might instead affect motor neuron transmitter release via a retrograde signal from its target muscle. To test this hypothesis, we determined whether laryngeal muscle expresses ER. With RT-PCR using primers that recognize highly conserved domains of the ERα, mRNA products of the predicted size were amplified from laryngeal muscle as well as from other classical target tissues (forebrain and oviduct). Northern blots using a portion of the PCR product as primer revealed the same-sized band in oviduct and laryngeal muscle. Immunocytochemistry and Western blots confirmed the presence of ER protein in laryngeal muscle fibers and revealed several proteins in laryngeal muscle, brain and liver; among these was an approximately 66-kD protein – presumed to be full-length ER – that was the only one found in oviduct. Estrogen treatment of juveniles resulted in an upregulation of the 66-kD ER protein concomitant with an increase in quantal content. Taken together, these experiments strongly suggest that the ER is expressed by laryngeal muscle; this receptor could mediate estrogen-dependent changes in synaptic strength via retrograde signaling.

1.
Hull E, Meisel R, Sachs B: Male sexual behavior; in Pfaff DW, Arnold AP, Etgen AM, Fahrbach SE, Rubon RT (eds): Hormones, Brain and Behavior. San Diego, Academic Press, 2002, pp 1–138.
2.
Goodwin J, Crews DP: Hormones, brain and behavior in reptiles; in Pfaff DW, Arnold AP, Etgen AM, Fahrbach SE, Rubon RT (eds): Hormones, Brain and Behavior. San Diego, Academic Press, 2002, pp 545–586.
3.
Schlinger BA, Brenowitz EA: Neural and hormonal control of birdsong; in Pfaff DW, Arnold AP, Etgen AM, Fahrbach SE, Rubon RT (eds): Hormones, Brain and Behavior. San Diego, Academic Press, 2002, pp 799–840.
4.
Kelley DB: Hormonal regulation of motor output in amphibians: Xenopus laevis vocalizations as a model system; in Pfaff DW, Arnold AP, Etgen AM, Fahrbach SE, Rubon RT (eds): Hormones, Brain and Behavior. San Diego, Academic Press, 2002, pp 445–467.
5.
Ogawa S, Taylor JA, Lubahn DB, Korach KS, Pfaff DW: Reversal of sex roles in genetic female mice by disruption of estrogen receptor gene. Neuroendocrinology 1996;64:467–470.
6.
Ogawa S, Lubahn DB, Korach KS, Pfaff DW: Behavioral effects of estrogen receptor gene disruption in male mice. Proc Natl Acad Sci USA 1997;94:1476–1481.
7.
Ogawa S, Chester AE, Hewitt SC, Walker VR, Gustafsson JA, Smithies O, Korach KS, Pfaff DW: Abolition of male sexual behaviors in mice lacking estrogen receptors alpha and beta (alpha beta ERKO). Proc Natl Acad Sci USA 2000;97:14737–14741.
8.
Breedlove SM, Jordan CK, Kelley DB: What neuromuscular systems tell us about hormones and behavior; in Pfaff DW, Arnold AP, Etgen AM, Fahrbach SE, Rubon RT (eds): Hormones, Brain and Behavior. San Diego, Academic Press, 2002, pp 193–222.
9.
Etgen AM, Chu HP, Fiber JM, Karkanias GB, Morales JM: Hormonal integration of neurochemical and sensory signals governing female reproductive behavior. Behav Brain Res 1999;105:93–103.
10.
Kelley DB, Tobias ML: The vocal repertoire of Xenopus laevis; in Hauser M, Konishi M (eds): The Design of Animal Communication. Cambridge, MIT, 1999, pp 9–-35.
11.
Kelley DB: Sexual differentiation in Xenopus laevis; in Tinsley RC, Kobel H (eds): The Biology of Xenopus. Oxford, Oxford University Press, 1996, pp 143–176.
12.
Tobias ML, Tomasson J, Kelley DB: Attaining and maintaining strong vocal synapses in female Xenopus laevis. J Neurobiol 1998;37:441–448.
13.
Wu KH, Tobias ML, Kelley DB: Estrogen and laryngeal synaptic strength in Xenopus laevis: Opposite effects of acute and chronic exposure. Neuroendocrinology 2001;74:22–32.
14.
Tobias ML, Kelley DB: Vocalizations by a sexually dimorphic isolated larynx: Peripheral constraints on behavioral expression. J Neurosci 1987;7:3191–3197.
15.
Tobias ML, Kelley DB: Sexual differentiation and hormonal regulation of the laryngeal synapse in Xenopus laevis. J Neurobiol 1995;28:515–526.
16.
Wu KH, Tobias ML, Thornton J, Kelley DB: Estrogen receptors in Xenopus: Duplicate genes, splice variants, and tissue-specific expression. Gen Comp Endocrinol, in press.
17.
Bisbee CA, Baker MA, Wilson AC, Haji-Azimi I, Fischberg M: Albumin phylogeny for clawed frogs (Xenopus). Science 1977;195:785–787.
18.
Tobias ML, Kelley DB, Ellisman M: A sex difference in synaptic efficacy at the laryngeal neuromuscular junction of Xenopus laevis. J Neurosci 1995;15:1660–1668.
19.
Morrell JI, Kelley DB, Pfaff DW: Autoradiographic localization of hormone-concentrating cells in the brain of an amphibian, Xenopus laevis. II. Estradiol. J Comp Neurol 1975;164:63–77.
20.
Kelley DB: Auditory and vocal nuclei in the frog brain concentrate sex hormones. Science 1980;207:553–555.
21.
Landmesser LT: Synaptic plasticity: Keeping synapses under control. Curr Biol 1998;8:R564–R567.
22.
Harlow E, Lane D: Using Antibodies. Cold Spring Harbor, Cold Spring Harbor Laboratory, 1988.
23.
Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680–685.
24.
Del Castillo J, Katz B: Quantal components of the end-plate potential. J Physiol 1954;124:560–573.
25.
Weiler IJ, Lew D, Shapiro DJ: The Xenopus laevis estrogen receptor: Sequence homology with human and avian receptors and identification of multiple estrogen receptor messenger ribonucleic acids. Mol Endocrinol 1987;1:355–362.
26.
Cox RF, Catlin GH, Carey NH: Studies on the mode of action of oestradiol on chicken oviduct. Characterisation of oestradiol receptor proteins. Eur J Biochem 1971;22:46–56.
27.
Sen KK, Talwar GP: Similarities and differences in the binding of oestradiol-17beta to rat oviduct and uterus. J Reprod Fertil 1973;35:369–372.
28.
Marsh J, Tata JR: Establishment and characterization of Xenopus oviduct cells in primary culture. Exp Cell Res 1987;173:117–128.
29.
Joensuu TK, Tuohimaa PJ: Ontogeny of the estrogen receptor in the chick oviduct. J Steroid Biochem 1989;34:293–296.
30.
VanderHorst VG, Meijer E, Schasfoort FC, Van Leeuwen FW, Holstege G: Estrogen receptor-immunoreactive neurons in the lumbosacral cord projecting to the periaqueductal gray in the ovariectomized female cat. Neurosci Lett 1997;236:25–28.
31.
Wood JR, Greene GL, Nardulli AM: Estrogen response elements function as allosteric modulators of estrogen receptor conformation. Mol Cell Biol 1998;18:1927–1934.
32.
Green S, Walter P, Greene G, Krust A, Goffin C, Jensen E, Scrace G, Waterfield M, Chambon P: Cloning of the human oestrogen receptor cDNA. J Steroid Biochem 1986;24:77–83.
33.
Gronemeyer H: Transcription activation by estrogen and progesterone receptors. Annu Rev Genet 1991;25:89–123.
34.
Kumar V, Green S, Stack G, Berry M, Jin JR, Chambon P: Functional domains of the human estrogen receptor. Cell 1987;51:941–951.
35.
Krust A, Green S, Argos P, Kumar V, Walter P, Bornert JM, Chambon P: The chicken oestrogen receptor sequence: Homology with v-erbA and the human oestrogen and glucocorticoid receptors. EMBO J 1986;5:891–897.
36.
Maxwell BL, McDonnell DP, Conneely OM, Schulz TZ, Greene GL, O’Malley BW: Structural organization and regulation of the chicken estrogen receptor. Mol Endocrinol 1987;1:25–35.
37.
White R, Lees JA, Needham M, Ham J, Parker M: Structural organization and expression of the mouse estrogen receptor. Mol Endocrinol 1987;1:735–744.
38.
Schreihofer DA, Resnick EM, Soh AY, Shupnik MA: Transcriptional regulation by a naturally occurring truncated rat estrogen receptor (ER), truncated ER product-1 (TERP-1). Mol Endocrinol 1999;13:320–329.
39.
Resnick EM, Schreihofer DA, Periasamy A, Shupnik MA: Truncated estrogen receptor product-1 suppresses estrogen receptor transactivation by dimerization with estrogen receptors alpha and beta. J Biol Chem 2000;275:7158–7166.
40.
Griffin C, Flouriot G, Sonntag-Buck V, Gannon F: Two functionally different protein isoforms are produced from the chicken estrogen receptor-alpha gene. Mol Endocrinol 1999;13:1571–1587.
41.
Griffin C, Flouriot G, Sharp P, Greene G, Gannon F: Distribution analysis of the two chicken estrogen receptor-alpha isoforms and their transcripts in the hypothalamus and anterior pituitary gland. Biol Reprod 2001;65:1156–1163.
42.
Fitzsimonds RM, Poo MM: Retrograde signaling in the development and modification of synapses. Physiol Rev 1998;78:143–170.
43.
Wang T, Xie Z, Lu B: Nitric oxide mediates activity-dependent synaptic suppression at developing neuromuscular synapses. Nature 1995;374:262–266.
44.
Xiao S, Gillespie DG, Baylis C, Jackson EK, Dubey RK: Effects of estradiol and its metabolites on glomerular endothelial nitric oxide synthesis and mesangial cell growth. Hypertension 2001;37:645–650.
45.
Takahashi W, Yoshida M, Wada Y, Goto S, Inadome A, Yono M, Ueda S: Effect of estrogen on nitric oxide-induced relaxation of the rabbit urethra. Eur J Pharmacol 1997;339:165–171.
46.
Al-Hijji J, Larsson I, Batra S: Effect of ovarian steroids on nitric oxide synthase in the rat uterus, cervix and vagina. Life Sci 2001;69:1133–1142.
47.
Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S: Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA 1994;91:5212–5216.
48.
Morschl E, Bretus I, Nemcsik J, Laszlo F, Pavo I: Estrogen-mediated up-regulation of the Ca-dependent constitutive nitric oxide synthase in the rat aorta and heart. Life Sci 2000;68:49–55.
49.
Harish OE, Poo MM: Retrograde modulation at developing neuromuscular synapses: Involvement of G protein and arachidonic acid cascade. Neuron 1992;9:1201–1209.
50.
Wang XH, Poo MM: Potentiation of developing synapses by postsynaptic release of neurotrophin-4. Neuron 1997;19:825–835.
51.
Wang CY, Yang F, He X, Chow A, Du J, Russell JT, Lu B: Ca2+ binding protein frequenin mediates GDNF-induced potentiation of Ca2+ channels and transmitter release. Neuron 2001;32:99–112.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.